Effects of iNO on Invasively Derived Pulmonary Vascular Parameters in Patients With Pulmonary Arterial Hypertension
Phase of Trial: Phase II
Latest Information Update: 23 May 2017
At a glance
- Drugs Nitric oxide (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- 23 May 2017 New trial record
- 07 Apr 2017 According to a Bellerophon Therapeutics Media Release, results presented at 37th Annual Meeting for the International Society for Heart and Lung Transplantation (ISHLT, 2017).
- 07 Apr 2017 Results published in a Bellerophon Therapeutics Media Release.